Authors:
Yokomizo, T
Ogawa, M
Osato, M
Kanno, T
Yoshida, H
Fujimoto, T
Fraser, S
Nishikawa, S
Okada, H
Satake, M
Noda, T
Nishikawa, SI
Ito, Y
Citation: T. Yokomizo et al., Requirement of Runx1/AML1/PEBP2 alpha B for the generation of haematopoietic cells from endothelial cells, GENES CELLS, 6(1), 2001, pp. 13-23
Authors:
Ozpolat, B
Actor, JK
Rao, XM
Lee, S
Osato, M
Graham, DY
Lachman, LB
Citation: B. Ozpolat et al., Quantitation of Helicobacter pylori in the stomach using quantitative polymerase chain reaction assays, HELICOBACT, 5(1), 2000, pp. 13-21
Authors:
Asou, N
Suzushima, H
Nishimura, S
Okubo, T
Yamasaki, H
Osato, M
Hoshino, K
Takatsuki, K
Mitsuya, H
Citation: N. Asou et al., Long-term remission in an elderly patient with mantle cell leukemia treated with low-dose cyclophosphamide, AM J HEMAT, 63(1), 2000, pp. 35-37
Authors:
Laine, L
Fennerty, MB
Osato, M
Sugg, J
Suchower, L
Probst, P
Levine, JG
Citation: L. Laine et al., Esomeprazole-based Helicobacter pylori eradication therapy and the effect of antibiotic resistance: Results of three US multicenter, double-blind trials, AM J GASTRO, 95(12), 2000, pp. 3393-3398
Authors:
Malaty, HM
Graham, DY
Wattigney, WA
Srinivasan, SR
Osato, M
Berenson, GS
Citation: Hm. Malaty et al., Natural history of Helicobacter pylori infection in childhood: 12-year follow-up cohort study in a biracial community, CLIN INF D, 28(2), 1999, pp. 279-282
Authors:
Breuer, T
Kim, JG
El-Zimaity, HM
Nikajima, S
Ota, H
Osato, M
Graham, DY
Citation: T. Breuer et al., Clarithromycin, amoxicillin and H-2-receptor antagonist therapy for Helicobacter pylori peptic ulcer disease in Korea (vol 11, pg 939, 1997), ALIM PHARM, 13(4), 1999, pp. 567-567
Authors:
Osato, M
Asou, N
Abdalla, E
Hoshino, K
Yamasaki, H
Okubo, T
Suzushima, H
Takatsuki, K
Kanno, T
Shigesada, K
Ito, Y
Citation: M. Osato et al., Biallelic and heterozygous point mutations in the runt domain of the AML1/PEBP2 alpha B gene associated with myeloblastic leukemias, BLOOD, 93(6), 1999, pp. 1817-1824